EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.
Fabian FalkenbachFrancesca AmbrosiniPierre TennstedtMatthias EiberMatthias M HeckFelix PreisserMarkus GraefenLars BudäusDaniel KoehlerSophie KnipperTobias MaurerPublished in: Cancers (2023)
The BCR risk groups and PSA kinetics do not predict the oncological success of PSMA-RGS performed at low absolute PSA values. Indolent low-risk BCR is rarely treated by PSMA-RGS.
Keyphrases
- prostate cancer
- pet ct
- radical prostatectomy
- pet imaging
- acute lymphoblastic leukemia
- tyrosine kinase
- minimally invasive
- positron emission tomography
- machine learning
- deep learning
- chronic myeloid leukemia
- coronary artery bypass
- computed tomography
- case report
- rectal cancer
- robot assisted
- coronary artery disease
- aqueous solution